314 related articles for article (PubMed ID: 29626596)
1. Renal histology in a patient with TAFRO syndrome: a case report.
Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y
Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596
[TBL] [Abstract][Full Text] [Related]
2. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
[TBL] [Abstract][Full Text] [Related]
3. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
[TBL] [Abstract][Full Text] [Related]
4. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
5. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
Fujiwara Y; Ito K; Takamura A; Nagata K
J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
[TBL] [Abstract][Full Text] [Related]
6. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients.
Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A
Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274
[TBL] [Abstract][Full Text] [Related]
8. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.
Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103
[TBL] [Abstract][Full Text] [Related]
9. TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report.
Noda-Narita S; Sumida K; Sekine A; Hoshino J; Mise K; Suwabe T; Hayami N; Yamanouchi M; Ueno T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Ohashi K; Fujii T; Ubara Y
CEN Case Rep; 2018 May; 7(1):162-168. PubMed ID: 29468524
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome.
Ozeki T; Tsuji M; Yamamoto J; Shigematsu C; Maruyama S
CEN Case Rep; 2018 Nov; 7(2):243-247. PubMed ID: 29766467
[TBL] [Abstract][Full Text] [Related]
12. A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
Minomo S; Fujiwara Y; Sakashita S; Takamura A; Nagata K
J Med Case Rep; 2021 Jan; 15(1):3. PubMed ID: 33402219
[TBL] [Abstract][Full Text] [Related]
13. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
Kurose N; Mizutani KI; Kumagai M; Shioya A; Guo X; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Kida M; Yamada S
Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741
[TBL] [Abstract][Full Text] [Related]
14. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
[TBL] [Abstract][Full Text] [Related]
15. An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions.
Hashimoto K; Sano T; Honma Y; Ida M; Tominaga H; Sawada A; Abe T; Takahashi H; Shimada Y; Masaki T; Kamata M; Naito S; Aoyama T; Takeuchi Y; Akiya M; Inukai M; Nakata N
CEN Case Rep; 2019 Feb; 8(1):48-54. PubMed ID: 30244358
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
[TBL] [Abstract][Full Text] [Related]
18. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
[TBL] [Abstract][Full Text] [Related]
20. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]